Preface

• Pages: 15-16

xv

PREFACE

The past decade has featured numerous high-profile decisions,

including that of the Supreme Court in FTC v. Actavis, that have

fundamentally influenced the advice that practitioners give to their

pharmaceutical clients. Thegoal of this updated edition of the Handbook,

as with the first edition, is to provide a comprehensive and objective source

about the most important antitrust issues faced by the pharmaceutical

industry today.

First and foremost, the creation of this Second Edition would not have

been possible without all of those who labored on the First Edition, and

the Health Care & Pharmaceuticals Committee would like to thank the

dozens of individuals who contributed to that effort.

Special thanks are also due to co-editors Jacqueline Grise and Richard

Coe, and the Books and Treatises Committee, particularly Brandon

Bigelow and Leo Caseria, all of whom spent substantial time and effort on

creating a high-quality, useful, and accessible guide. These primary

editors were aided by numerous others, including authors who contributed

content, and editors who reviewed each chapter to ensure an objective and

balanced perspective, and who proofread, formatted, cite-checked, and

implemented edits after each round of review.

The names of the authors and editors who made this Second Edition

possible are listed below. We would also like to thank the associates,

librarians, paralegals, secretaries, and other law firm staff members who

might not themselves be named below but who provided invaluable

support to the authors and editors.

Editorial Chairs

Jacqueline Grise

Richard Coe